TRPA1 and demyelinating disease: A possible role of TRPA1 has been reported in models of MS, and in a mouse model of the demyelinating disease induced by cuprizone, where the activation of astrocyte expressing TRPA1 elicits the release of pro-inflammatory mediators contributing to oligodendrocyte apoptosis [17].